Canadian Medical Center Co. (4021.SR) — Cash flow
Operating, investing, and financing cash flow for Canadian Medical Center Co. — annual and quarterly.
| Metric (SAR Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Operating Activities | ||||||
| Net Income | 10↑2.2% | 10↓42.5% | 18↓0.6% | 18↑8.7% | 17 | |
| Depreciation & Amortization | 7↑61.6% | 4↑132.3% | 2↓44.8% | 3↑7.0% | 3 | |
| Deferred Income Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Stock-Based Compensation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Changes in Working Capital | -6↑50.8% | -13↑2.4% | -13↓279.6% | -3↑81.5% | -18 | |
| Accounts Receivable | -16↓15.5% | -14↓12.0% | -12↓1238.5% | -0.91↑95.1% | -18 | |
| Inventory | -0.44↓161.5% | 0.71↑63.9% | 0.43↑116.4% | -3↓54.2% | -2 | |
| Accounts Payable | 11↑1064.6% | 0.93↑38.5% | 0.67↑9.1% | 0.62↓68.8% | 2 | |
| Other Working Capital | -0.91↓35.8% | -0.67↑64.6% | -2↓305.0% | -0.47↓74.1% | -0.27 | |
| Other Non-Cash Items | 9↑270.1% | 2↓59.8% | 6↑615.6% | -1↓330.9% | 0.51 | |
| Net Cash from Operating Activities | 20↑380.8% | 4↓67.6% | 13↓22.8% | 17↑939.3% | 2 | |
| Operating Cash Flow | 20↑380.8% | 4↓67.6% | 13↓22.8% | 17↑939.3% | 2 | |
| Investing Activities | ||||||
| Investment in Property, Plant & Equipment | -9↓16.5% | -8↓138.1% | -3↓3226.4% | -0.10↑93.8% | -2 | |
| Capital Expenditure | -9↓16.5% | -8↓138.1% | -3↓3226.4% | -0.10↑93.8% | -2 | |
| Acquisitions | 0.05↓55.7% | 0.11↑34.9% | 0.08↑100.6% | -15↓211648.6% | 0.01 | |
| Purchases of Investments | -35↓0.9% | -35 | 0.00↑100.0% | -55↑6.8% | -59 | |
| Sales & Maturities of Investments | 35 | 0.00↓100.0% | 46↓34.1% | 70↑1005413.9% | -0.01 | |
| Other Investing Activities | 0.00 | 0.00 | 0.00↓100.0% | 15↑211448.6% | 0.01 | |
| Net Cash from Investing Activities | -9↑78.3% | -43↓200.7% | 43↑192.9% | 15↑124.0% | -61 | |
| Financing Activities | ||||||
| Net Debt Issuance | 0.00↑100.0% | -3↓161.7% | -1↑58.7% | -3↓48.0% | -2 | |
| Long-Term Net Debt Issuance | 0.00↑100.0% | -3↓161.7% | -1↓5.1% | -1↓13.8% | -0.95 | |
| Short-Term Net Debt Issuance | 0.00 | 0.00 | 0.00↑100.0% | -3↓203.3% | -0.91 | |
| Net Stock Issuance | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Common Stock Issuance | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Common Stock Issuance | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Share Buybacks | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Preferred Stock Issuance | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Dividends Paid | -8↓11.1% | -7↑40.0% | -12↑50.0% | -23↓100.0% | -12 | |
| Common Dividends Paid | -8↓11.1% | -7↑40.0% | -12↑50.0% | -23↓100.0% | -12 | |
| Preferred Dividends Paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other Financing Activities | -3 | 0.00 | 0.00↑100.0% | -1↓13.8% | -0.95 | |
| Net Cash from Financing Activities | -11↓11.4% | -10↑21.9% | -13↑52.9% | -27↓87.5% | -14 | |
| Cash Reconciliation | ||||||
| Effect of Foreign Exchange | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Change in Cash | -0.46↑99.1% | -49↓214.0% | 43↑930.6% | 4↑105.6% | -73 | |
| Cash at Beginning of Period | 5↓91.3% | 53↑400.8% | 11↑63.6% | 7↓91.9% | 80 | |
| Cash at End of Period | 4↓9.9% | 5↓91.3% | 53↑400.8% | 11↑63.6% | 7 | |
| Income Taxes Paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Interest Paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Free Cash Flow | 11↑370.0% | -4↓141.5% | 9↓42.8% | 16↑36215.4% | -0.05 | |
* All figures in Millions of SAR, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.